References
- AlmACamrasCBWatsonPGPhase III latanoprost studies in Scandinavia, the United Kingdom and the United StatesSurvey of Ophthalmology1997412S105S11010.1016/S0039-6257(97)80016-1
- AndersonDRCollaborative normal tension glaucoma studyCurrent Opinion in Ophthalmology2003142869010.1097/00055735-200304000-00006
- BalciOValidation, verification, and testing techniques throughout the life cycle of a simulation studyAnnals of Operations Research199453112117310.1007/BF02136828
- BathijaRGuptaNZangwillLWeinrebRNChanging definition of glaucomaJournal of Glaucoma19987316516910.1097/00061198-199806000-00004
- BeckersHSchoutenJWebersCvan Der ValkRHendrikseFSide effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfactionGraefe's Archive for Clinical and Experimental Ophthalmology2008246101485149010.1007/s00417-008-0875-7
- BrailsfordSCHarperPRPatelBPittMAn analysis of the academic literature on simulation and modelling in health careJournal of Simulation20093313014010.1057/jos.2009.10
- BurrJMKilonzoMValeLRyanMDeveloping a preference-based Glaucoma Utility Index using a discrete choice experimentOptomometry & Vision Science200784879780810.1097/OPX.0b013e3181339f30
- ChristensenTLPoulsenPBHolmstromSWaltJGVetrugnoMA Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in ItalyCurrent Medical Research and Opinion200521111837184310.1185/030079905X65592
- CravenERWaltersTRWilliamsRChouCCheethamJKSchiffmanRBrimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertensionJournal of Ocular Pharmacology and Therapeutics200521433734810.1089/jop.2005.21.337
- DavidRLivingstonDGLuntzMHOcular hypertension – a long-term follow-up of treated and untreated patientsBritish Journal of Ophthalmology1977611166867410.1136/bjo.61.11.668
- FoneDSystematic review of the use and value of computer simulation modelling in population health and health care deliveryJournal of Public Health20032532533510.1093/pubmed/fdg075
- GunalMMA guide for building hospital simulation modelsHealth Systems201211172510.1057/hs.2012.8
- GunalMMPiddMDiscrete event simulation for performance modelling in health care: a review of the literatureJournal of Simulation201041425110.1057/jos.2009.25
- HamacherTShort term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapiesBritish Journal of Ophthalmology200488101295129810.1136/bjo.2004.043232
- HigginbothamEJConsiderations in glaucoma therapy: fixed combinations versus their component medicationsClinical Ophthalmology2010419
- HigginbothamEJThe ocular hypertension treatment study: topical medication delays or prevents primary open-angle glaucoma in African American individualsArchives of Ophthalmology2004122681382010.1001/archopht.122.6.813
- JackwayPTDesilvaBMA methodology for initialization bias reduction in computer simulation outputAsia-pacific Journal of Operational Research1992987100
- JahnBPfeifferKPTheurlETarrideJ-EGoerreeRCapacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stentsMedical Decision Making201030162810.1177/0272989X09336075
- JunJBJacobsonSHSwisherJRApplication of discrete-event simulation in health care clinics: a surveyThe Journal of the Operational Research Society199950210912310.1057/palgrave.jors.2600669
- JuzychMSComparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucomaOphthalmology2004111101853185910.1016/j.ophtha.2004.04.030
- KarnonJStahlJEBrennanACaroJJMarJMöllerJModeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4Value in Health201215682182710.1016/j.jval.2012.04.013
- KarnonJVanniTCalibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteriaPharmacoeconomics2011291516210.2165/11584610-000000000-00000
- KatsaliakiKMustafeeNApplications of simulation within the healthcare contextJournal of the Operational Research Society20116281431145110.1057/jors.2010.20
- KingmanSGlaucoma is second leading cause of blindness globallyBulletin of the World Health Organization20048211887888
- KobeltGJonssonLGerdthamUKrieglsteinGKDirect costs of glaucoma management following initiation of medical therapy: a simulation model based on an observational study of glaucoma treatment in GermanyGraefes Archive for Clinical and Experimental Ophthalmology19982361181182110.1007/s004170050165
- KymesSMThe development of a decision analytic model of changes in mean deviation in people with Glaucoma: the COA modelOphthalmology201211971367137410.1016/j.ophtha.2012.01.054
- LawAKeltonWSimulation Modeling and Analysis2000
- LichterPRInterim clinical outcomes in the collaborative initial Glaucoma treatment study comparing initial treatment randomized to medications or surgeryOphthalmology2001108111943195310.1016/S0161-6420(01)00873-9
- NordmannJPMertzBYannoulisNCSchwenningerCKapikBShamsNA double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension: 6 month dataAmerican Journal of Ophthalmology2002133111010.1016/S0002-9394(01)01337-X
- RahmanMQMontgomeryDMILazaridouMNSurveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 years’ experienceBritish Journal of Ophthalmology200993121572157510.1136/bjo.2008.151522
- RazeghinejadMRSawchynAKKatzLJFixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucomaExpert Opinion on Pharmacotherapy201011695996810.1517/14656561003667540
- RuloAHGreveELHoyngPFAdditive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressureBritish Journal of Ophthalmology1994781289990210.1136/bjo.78.12.899
- RutterCMZaslavskyAMFeuerEJDynamic microsimulation models for health outcomes: a reviewMedical Decision Making2010311101810.1177/0272989X10369005
- SchwartzGFQuigleyHAAdherence and persistence with Glaucoma therapySurvey of Ophthalmology2008536, Supplement 1S57S6810.1016/j.survophthal.2008.08.002
- SEAGIG. (2003) Asia Pacific Glaucoma Guidelines South (East Asia glaucoma interest group). 1–92.
- SleathBBallingerRCovertDRobinALByrdJETudorGSelf-reported prevalence and factors associated with nonadherence with glaucoma medications in veteran outpatientsThe American Journal of Geriatric Pharmacotherapy200972677310.1016/j.amjopharm.2009.04.001
- StahlJEModelling methods for pharmacoeconomics and health technology assessment: an overview and guidePharmacoeconomics200826213114810.2165/00019053-200826020-00004
- StewartWCStewartJAMychaskiwMACost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic modelEye (London)200923113214010.1038/sj.eye.6702964
- SunXLaser peripheral iridotomy with and without iridoplasty for primary angle-closure glaucoma: 1-year results of a randomized pilot studyAmerican Journal of Ophthalmology20101501687310.1016/j.ajo.2010.02.004
- TaylorHRCrowstonJKeeffeJPezulloLTaylorPMoorePTunnel Vision: The Impact of Primary Open Angle Glaucoma – A Dynamic Economic Model2008
- The Advanced Glaucoma Intervention Study Investigators (1994) The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Controlled Clinical Trials 15 (4), 299–325.
- US Social Security Administration. (2010) Disability Evaluation Under Social Security 2.00 Special Senses and Speech – Adult. U.S. Social Security Administration, USA.
- van GestelASeverensJLWebersCABeckersHJJansoniusNMSchoutenJSModeling complex treatment strategies: construction and validation of a discrete event simulation model for glaucomaValue Health201013435836710.1111/j.1524-4733.2009.00678.x
- VanniTCalibrating models in economic evaluation: a seven-step approachPharmacoeconomics2011291354910.2165/11584600-000000000-00000
- WangMClinical observation of trabeculectomy for primary angle closure glaucomaZhonghua Yan Ke Za Zhi2009454338343
- YükselNAltintaşÖKarabaşLAlpBÇağlarYThe short-term effect of adding Brimonidine 0.2% to Timolol treatment in patients with Open-Angle GlaucomaOphthalmologica1999213422823310.1159/000027427
- ZhouZAlthinRSforzoliniBSDhawanRPersistency and treatment failure in newly diagnosed open angle glaucoma patients in the United KingdomBritish Journal of Ophthalmology200488111391139410.1136/bjo.2003.037713